Cases 1 - 10 of 22
Barnes v. Boehringer Ingelheim Corporation et al
as 3:2023cv18146
Plaintiff:
Kathy Barnes
Defendant:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
KATHY BARNES v. Ajanta Pharma USA Inc et al
as 3:2023cv17035
Plaintiff:
KATHY BARNES AND REPRESENTATIVES & HEIRS TO THE ESTATE OF CASEY BARNES and Kathy Barnes
Defendant:
Ajanta Pharma USA Inc, Albertson's Companies Inc., Amneal Pharmaceuticals of New York, LLC and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
In re: Leatha Taylor, et al v. Bristol-Myers Squibb Company, et al
as 22-6078
Not Classified By Court:
In re: ONGLYZA (SAXAGLIPTIN) AND KOMBIGLYZE (SAXAGLIPTIN AND METFORMIN) PRODUCTS LIABILITY LITIGATION MDL 2809
Plaintiff / Appellant:
LEATHA TAYLOR, Individually and as Administratrix of Estate of David Taylor, KATHY BARNES, LISA ARLENE PEOPLES and others
Defendant / Appellee:
BRISTOL-MYERS SQUIBB COMPANY, ASTRAZENECA PHARMACEUTICALS LP, IPR PHARMACEUTICALS INC. and others
Barnes et al v. Progressive Specialty Insurance Company
as 2:2020cv01782
Plaintiff:
Jason Barnes and Kathy Barnes
Defendant:
Progressive Specialty Insurance Company
Cause Of Action: 28 U.S.C. § 1441
BARNES v. JOHNSON AND JOHNSON et al
as 3:2020cv11748
In Re:
JOHNSON & JOHNSON TALCUM POWDER PRODUCTS MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION
Defendant:
PERSONAL CARE PRODUCTS COUNCIL, JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. and JOHNSON AND JOHNSON
Plaintiff:
KATHY BARNES
Cause Of Action: 28 U.S.C. § 1332
Barnes-Gordon v. Sanofi US Services Inc. et al
as 2:2018cv11089
Defendant:
Sanofi-Aventis U.S. LLC and Sanofi US Services Inc.
Plaintiff:
Kathy Barnes-Gordon
Cause Of Action: 28 U.S.C. § 1332
Barnes v. Bristol-Myers Squibb Company et al
as 5:2018cv00054
Plaintiff:
Kathy Barnes
Defendant:
Bristol-Myers Squibb Company , AstraZeneca Pharmaceuticals LP and McKesson Corporation
Cause Of Action: 28 U.S.C. § 1332
In re: Onglyza (Saxagliptin) and Kombiglyze (Saxagliptin and Metformin) Products Liability Litigation MDL 2809
as 5:2018md02809
Defendant:
Onglyza (Saxagliptin) and Kombiglyze (Saxagliton and Metformin) Products Liability Litigation MDL 2809, McKesson Corporation, Bristol-Myers Squibb Company, Inc. and others
Plaintiff:
Susan Settle, Charles David Ware, William Dinger Sr. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Barnes v. Bristol-Myers Squibb Company et al
as KYE/2:17-cv-00124
Plaintiff:
Kathy Barnes
Defendant:
Bristol-Myers Squibb Company , AstraZeneca Pharmaceuticals LP and McKesson Corporation
Barnes v. Bristol-Myers Squibb Company et al
as 2:2017cv00124
Plaintiff:
Kathy Barnes
Defendant:
Bristol-Myers Squibb Company , AstraZeneca Pharmaceuticals LP and McKesson Corporation
Cause Of Action: 28 U.S.C. § 1332
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
